Roche builds MRD testing arsenal in $595m Saga Diagnostics buyout
Roche has agreed to acquire molecular residual disease (MRD) specialist, Saga Diagnostics and its platform in a $595m bid – …
Post
-
-
GE and DeepHealth expand partnership for breast screening solutions
GE HealthCare has expanded its partnership with RadNet subsidiary DeepHealth to broaden access to AI-powered breast cancer screening solutions. The agreement …
-
Biomarker-led trials to guide the future of precision psychiatry
As the neuroscience treatment landscape continuously evolves towards the wider use of precision treatment options, biomarker-led trials are emerging as …
-
Philips secures FDA clearance for Verida spectral CT system
Philips has received 510(k) clearance from the US Food and Drug Administration (FDA) for its Verida system. The device is an …
-
Stereotaxis to acquire Robocath for up to $45m
US medical technology company Stereotaxis has agreed to acquire smart robotic solutions developer Robocath in a deal worth up to …
-
Phantom Neuro secures approval for muscle-machine interface trial
Phantom Neuro has secured approval to initiate its first-in-human trial of the Phantom X system, a minimally invasive muscle-machine interface, …
-
Sonire Therapeutics raises $18m for tumour ablation platform advancement
Sonire Therapeutics has raised $18m towards supporting the ongoing clinical advancement of its non-invasive thermal ablation tumour treatment system. The Tokyo, …
-
Calyxo raises $40m to advance kidney stone removal system
Calyxo has raised $40m in a financing round; at the same time, the company has achieved a milestone of 40,000 …
-
FDA grants Protaryx Medical clearance for transseptal puncture device
Protaryx Medical has received the US Food and Drug Administration (FDA) 510(k) clearance to market its proprietary transseptal puncture device. The …
-
AIP to acquire Avanos Medical for $1.27bn
US-based Avanos Medical has entered a definitive agreement to be acquired by affiliates of American Industrial Partners (AIP) in an …
-
Boston Scientific touts 65% efficacy for Farapulse PFA in persistent AF trial
Boston Scientific has shared efficacy data for its Farapulse pulsed-field ablation (PFA), recording 65% efficacy for the system at one …
-
ProSomnus secures FDA clearance for RPMO2 device
ProSomnus Sleep Technologies has received the US Food and Drug Administration (FDA) Class II 510(k) clearance for its RPMO₂ OSA …
-
Heartflow sues Cleerly over patent infringement allegations
Heartflow has filed a lawsuit against Cleerly, alleging that three of the Texas-based company’s artificial intelligence (AI)-based tools for coronary …
-
J&J reports 12-month data for Varipulse PFA platform
Johnson & Johnson (J&J) has reported interim 12-month results from the VARIPURE study, assessing the effectiveness and safety of its …
-
Stryker agrees to acquire IVL developer Amplitude Vascular Systems
Stryker has agreed to acquire Amplitude Vascular Systems (AVS) in a move to broaden the medtech giant’s vascular care portfolio …
